BD (NYSE:BDX) announced today that it acquired Venclose and its solutions for treating chronic venous insufficiency (CVI).
CVI occurs as the result of malfunctioning valves and can lead to varicose veins. Venclose’s CVI treatment uses radio frequency (RF) ablation technology, with its catheters capable of potentially reducing post-operative pain and bruising compared to alternative laser treatment therapy.
The Venclose system has a compact design with two heating length sizes (2.5 cm and 10 cm) in one 6 FR-sized catheter, enabling physicians to effectively ablate more vein during each heating cycle through its increased heating length when compared to competitive RF ablation catheters, according to a news release.
Dual-heating allows physicians to ablate both long and short vein segments with the same catheter, reducing inventory management burden compared to catheters with shorter and/or static heating length sizes. The system also has a touchscre…